HRT FINANCIAL LP - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$2,820
-74.7%
103,916
-71.4%
0.03%
-73.1%
Q2 2023$11,150
+135.7%
362,739
+203.1%
0.10%
+55.2%
Q4 2022$4,730
-99.8%
119,689
+98.5%
0.07%
+139.3%
Q2 2022$2,534,000
-80.1%
60,283
-80.6%
0.03%
-76.1%
Q2 2021$12,743,000
+273.8%
310,887
+342.6%
0.12%
+14.7%
Q2 2020$3,409,00070,2340.10%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2021
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders